Denčić, T.; Petrović, A.; Jovičić Milentijević, M.; Radenković, G.; Jović, M.; Živković, N.; Šalinger, S.; Branković, B.; Veličkov, A.; Ilić, I.
The Importance of Immunohistochemical Heterogeneous Expression of MMR Protein in Patients with Colorectal Cancer in Stage II and III of the Disease. Medicina 2023, 59, 489.
https://doi.org/10.3390/medicina59030489
AMA Style
Denčić T, Petrović A, Jovičić Milentijević M, Radenković G, Jović M, Živković N, Šalinger S, Branković B, Veličkov A, Ilić I.
The Importance of Immunohistochemical Heterogeneous Expression of MMR Protein in Patients with Colorectal Cancer in Stage II and III of the Disease. Medicina. 2023; 59(3):489.
https://doi.org/10.3390/medicina59030489
Chicago/Turabian Style
Denčić, Tijana, Aleksandar Petrović, Maja Jovičić Milentijević, Goran Radenković, Marko Jović, Nikola Živković, Sonja Šalinger, Branko Branković, Aleksandra Veličkov, and Ivan Ilić.
2023. "The Importance of Immunohistochemical Heterogeneous Expression of MMR Protein in Patients with Colorectal Cancer in Stage II and III of the Disease" Medicina 59, no. 3: 489.
https://doi.org/10.3390/medicina59030489
APA Style
Denčić, T., Petrović, A., Jovičić Milentijević, M., Radenković, G., Jović, M., Živković, N., Šalinger, S., Branković, B., Veličkov, A., & Ilić, I.
(2023). The Importance of Immunohistochemical Heterogeneous Expression of MMR Protein in Patients with Colorectal Cancer in Stage II and III of the Disease. Medicina, 59(3), 489.
https://doi.org/10.3390/medicina59030489
